注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Pyxis Oncology Inc是一家肿瘤学公司。该公司专注于开发下一代疗法,以针对难以治疗的癌症并改善患者的生活质量。该公司利用其完全整合的研究、开发和商业能力来建立多元化的下一代治疗产品组合。该公司的治疗候选药物旨在直接杀死肿瘤细胞并解决癌症造成的潜在病理,使其无法控制增殖和免疫逃避。该公司已开发出广泛的新型抗体药物偶联物(ADC)、免疫肿瘤学(IO)、候选产品和单克隆抗体(mAb)产品组合,以及作为单一疗法并与其他疗法相结合的临床前发现项目。该公司产品管线为PYX-201和PYX-106。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Darren S. Cline | 60 | 2021 | Independent Director |
Robert Baffi | - | - | Member of Technical Advisory Board |
Michael Sun | - | - | Member of Technical Advisory Board |
Thomas Civik | 55 | 2021 | Independent Director |
Freda C. Lewis-Hall | 69 | 2021 | Independent Director |
Jason J. Luke | - | - | Member of Clinical & Translational Medicine Advisory Board |
Virgil Bryan Lawlis | - | - | Member of Technical Advisory Board |
Anthony W. Tolcher | - | 2021 | Member of Clinical & Translational Medicine Advisory Board |
Christopher O’Donnell | 54 | 2021 | Member of Technical Advisory Board |
Morris Rosenberg | - | - | Chairperson of Technical Advisory Board |
Jakob Dupont | 59 | 2023 | Independent Director |
Rachel Wallach Humphrey | 63 | 2022 | Independent Director |
Elliott M. Levy | 66 | 2023 | Member of Clinical & Translational Medicine Advisory Board |
Patricia LoRusso | - | 2023 | Member of Clinical & Translational Medicine Advisory Board |
Giulio Draetta | - | 2023 | Member of Clinical & Translational Medicine Advisory Board |
Glenn A. Miller | - | 2023 | Member of Clinical & Translational Medicine Advisory Board |
Paul A. Bunn | - | 2023 | Member of Clinical & Translational Medicine Advisory Board |
Santhosh Palani | 40 | 2024 | Independent Director |
Lara S. Sullivan | - | 2019 | CEO, President & Director |
John L. Flavin | 53 | 2019 | Independent Chairman |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核